Top View
- Gynaecological Uses of Dienogest Alone and in Combination with Oestrogens V
- United States Patent (10) Patent No.: US 7,297,688 B2 Grubb (45) Date of Patent: Nov
- Summary of Data Reported and Evaluation
- Combined Oral Contraceptives
- The Oestrogenic Effects of Gestodene, a Potent Contraceptive Progestin, Are Mediated by Its A-Ring Reduced Metabolites
- Nuv Aring® (Etonogestrel/Ethinyl Estradiol V Aginal Ring)
- Discerning Endometriosis As a Multifaceted Entity: a Comprehensive Review
- NHS Tayside Hormonal Contraception Guide: NHS Tayside Formulary, Pharmacological Content and Other Characteristics
- SUMMARY of PRODUCT CHARACTERISTICS 1. NAME of the MEDICINAL PRODUCT Ethinylestradiol + Gestodene Phagecon 0.015Mg/0.060 Mg Film
- X]*Premenstrual Dysphoric Disorder K584.00 Premenstrual Tension Syndrome *[X] Implies a Code Cross References to a Specific ICD10 Code
- Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; a Comparative-Safety Study
- (12) United States Patent (10) Patent No.: US 8,580,771 B2 Schramm Et Al
- BP503.T. PHARMACOLOGY-II (Theory) Subject Note Prepared By
- Gestodene and Ethinylestradiol Tablets MINESSE Tablets
- Package Leaflet: Information for the User Gestodette 0.075 Mg / 0.02 Mg
- Assessment Report for Combined Hormonal Contraceptives Containing Medicinal Products
- Combined Life Cycle Assessment and Life Cycle Costing of UV-Based Treatment of Emerging Contaminants Ekaterina Rokhina, Tony Singh, Marianne Curran, Rominder Suri
- NTP Protocol
- Australlian Product Information - Minulet (Gestodene and Ethinylestradiol) Tablets
- Choosing a Combined Oral Contraceptive Pill
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Bioequivalence of Two Oral Contraceptive Drugs Containing Ethinylestradiol and Gestodene in Healthy Female Volunteers
- Pharmacology of Progestogens Kuhl H J
- Official Title: the Effect of Isotretinoin on the Etonogestrel Contraceptive
- Gestilla, Overtrukne Tabletter
- Minutes of PRAC Meeting on 03-06 September 2018
- Gestodene and Desogestrel Do Not Have a Different Influence On
- Hormonal Treatments for Preventing Recurrence of Endometriomas
- Pharmacology/Therapeutics Ii Block Iii Handouts – 2016-17
- 3.2.3 Risks of Severe Depression, Anxiety and Suicidal Ideation with Hormonal Title Contraceptives Submitted by Medsafe Pharmacovigilance Team Paper Type for Advice